Common Contracts

Contract

Clinical Trial Agreement • May 22nd, 2023

• Contract Type
  Clinical Trial Agreement
• Filed
  May 22nd, 2023

AM ENDM ENT # 2 TO THE CLINICAL TRIAL AGREEM ENT PROTOCOL # 17000139BLC3002 DODATEK 2 KE SM LOUVĚ O KLINICKÉM HODNOCENÍ PROTOKOL # 17000139BLC3002 This Amendment #2 (“ Amendment”) to the Clinical Trial Tento dodatek číslo 2 (Dodatek) ke smlouvě o klinickém Agreement (“ Agreement” ) shall enter into effect on and hodnocení („smlouva“) je účinný k datu uveřejnění become effective as of the date of publication into the v Registru smluv České republiky („ datum účinnosti“) Register of Cont racts in the Czech Republic (“ Effective Date” ) Between Uzavřený mezi Janssen – Cilag International N.V. Janssen – Cilag International N.V. with registered offices at: Turnhoutseweg 30, 2340 se sídlem na adrese: Turnhoutseweg 30, 2340 Beerse, Beerse, Belgium Belgie Registration No.: BE0461607459Represented by the Power of Attorney by the companyJanssen-Cilag s.r.o. Registrační č.: BE0461607459zastoupenou na základě plné moci společnostíJanssen-Cilag s.r.o. with registered offices at Walterovo nám